Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

57.87USD
3:05pm EDT
Change (% chg)

$0.13 (+0.23%)
Prev Close
$57.74
Open
$57.51
Day's High
$57.88
Day's Low
$56.81
Volume
11,494
Avg. Vol
9,833
52-wk High
$62.45
52-wk Low
$38.12

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.64
Market Cap(Mil.): $421.21
Shares Outstanding(Mil.): 7.29
Dividend: --
Yield (%): --

Financials

  BSTC.OQ Industry Sector
P/E (TTM): 28.64 108.45 32.71
EPS (TTM): 2.02 -- --
ROI: 19.06 1.54 12.72
ROE: 19.78 0.30 14.84

BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54

* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $142.76 +0.78
Novartis AG (NOVN.S) CHF81.88 -0.06
Pfizer Inc. (PFE.N) $44.05 +0.30
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Merck & Co., Inc. (MRK.N) $71.29 +0.51
Bayer AG (BAYGn.DE) €76.52 +0.70
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.50 -0.17
GlaxoSmithKline plc (GSK.L) 1,531.40 +45.60

Earnings vs. Estimates